Register entryShortage reported

The Ritedose Corporation

Registered sites
1
Drug products
12
Live patents
0
Countries
1
Base
United States
Authorisation

Registered operations

What the FDA has registered these sites to do. This is the regulatory record, not a marketing claim.

Analytical testingLabellingFinished drug manufacturePackagingRepackaging
Sites

Facilities

1
SiteLocationOperationsFEI
The Ritedose CorporationColumbia, SCUnited StatesAnalytical testing, Labelling, Finished drug manufacture, Packaging, Repackaging3001237796
Alert

Products in shortage

1
DrugPresentationAvailability
Albuterol Sulfate SolutionAlbuterol Sulfate, Solution, 2.5 mg/.5 mL (NDC 76204-027-01)Available
Catalogue

Marketed products

12

Showing 12 of 12.

BrandGeneric nameFormCategory
Albuterol SulfateAlbuterol SulfateSOLUTIONANDA
Albuterol Sulfate Inhalation SolutionAlbuterol SulfateSOLUTIONANDA
Albuterol Sulfate Inhalation SolutionAlbuterol SulfateSOLUTIONANDA
Albuterol Sulfate Inhalation Solution, 0.5%Albuterol SulfateSOLUTIONANDA
Arformoterol Tartrate Inhalation SolutionArformoterol Tartrate Inhalation SolutionSOLUTIONANDA
Formoterol Fumarate Inhalation Solutionformoterol fumarate dihydrateSOLUTIONANDA
IPRATROPIUM BROMIDE AND ALBUTEROL SULFATEIpratropium Bromide and Albuterol SulfateSOLUTIONANDA
Ipratropium BromideIpratropium BromideSOLUTIONANDA
LevalbuterolLevalbuterol HydrochlorideSOLUTIONANDA
LevalbuterolLevalbuterol HydrochlorideSOLUTIONANDA
LevalbuterolLevalbuterol HydrochlorideSOLUTIONANDA
TobramycinTobramycinSOLUTIONANDA
Provenance

Facility and operations data from the FDA Drug Establishments Current Registration Site. Product data from the openFDA National Drug Code Directory. Patent and exclusivity data from the FDA Orange Book. Shortage data from the FDA drug shortage database. Contact details the FDA publishes for registered establishments are deliberately not reproduced here. This entry is compiled from public records and has not been claimed by the company.